Live Breaking News & Updates on Anthonye Lang

Stay updated with breaking news from Anthonye lang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Scientists Propose "Radically Different" New Way of Looking at Parkinson's Disease

Scientists propose a new model for classifying Parkinson’s. The complexity of Parkinson's disease poses significant challenges in developing effective treatments. This complexity stems from various causes, including genetics and environmental factors, coupled with the broad spectrum of symptoms tha ....

Ron Postuma , A Jon Stoessl , Charlesh Adler , Ronald Postuma , Tiagof Outeiro , Christine Klein , Daniela Berg , Werner Poewe , Anthonye Lang , Webster Foundation , Neuro Montreal Neurological Institute , Canadian Institutes Of Health Research , Hospital Of Mcgill University , Michaelj Fox Foundation For Parkinson Research , Weston Garfield Foundation , Parkinson Society Of Canada , National Institute Of Health , Canada Foundation For Innovation , Neurons Parkinson , Lewy Body Disease , Lancet Neurology , Montreal Neurological Institute Hospital , Mcgill University , Jon Stoessl , Canada Foundation , Canadian Institutes ,

Monoclonal Antibodies No Better Than Placebo for Early Parkinson Disease

The monoclonal antibodies cinpanemab and prasinezumab show almost no benefit for early Parkinson disease. ....

Gennaro Pagano , Prothena Biosciences , Anthonye Lang , Roche Innovation Center Basel , University Of Toronto , Movement Disorder , Healthday News , New England Journal , Movement Disorder Society Sponsored , Unified Parkinson , Disease Rating Scale ,

Monoclonal Antibodies No Better Than Placebo for Early Parkinson Disease

The monoclonal antibodies cinpanemab and prasinezumab show almost no benefit for early Parkinson disease. ....

Gennaro Pagano , Prothena Biosciences , Anthonye Lang , Roche Innovation Center Basel , University Of Toronto , Movement Disorder , Healthday News , New England Journal , Movement Disorder Society Sponsored , Unified Parkinson , Disease Rating Scale ,

Monoclonal Antibodies No Better Than Placebo for Early Parkinson Disease

Two studies show lack of benefit in primary or secondary end points with cinpanemab or prasinezumab versus placebo. ....

Gennaro Pagano , Prothena Biosciences , Anthonye Lang , Roche Innovation Center Basel , University Of Toronto , Movement Disorder , Healthday News , New England Journal , Movement Disorder Society Sponsored , Unified Parkinson , Disease Rating Scale ,

COVID-19 Collection

COVID-19 Collection
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Yu Shu Lin , United States , United Arab Emirates , South Korea , South Korean , Ben Goldacre , Susheela Balasundaram , Alvin Kuowei Tay , Andrea Cipriani , Adelaida Arboleda Trujillo , Sandra Reyes Beaman , G David Batty , Josef Finsterer , Toshia Furukawa , Benedetta Vai , Emmanuel Kiiza Mwesiga , Luiz Dratcu , Benedict Weobong , Leena Amiri , Johnr Geddes , Noeline Nakasujja , Jing Syuan Huang , Victor Mazereel , Richard Croker , Brandona Kohrt ,